FIELD: medicine, organic chemistry.
SUBSTANCE: invention relates to a stimulating agent for expression of MAG (myelin-associated glycoprotein) comprising compound of the formula (1):
.
The compound is useful for treatment of diseases comprising hypomyelinization, dysmyelinization or demyelinization.
EFFECT: valuable medicinal properties of compounds.
30 cl, 5 dwg, 5 ex
Title | Year | Author | Number |
---|---|---|---|
AZABIPHENYLAMINOBENZOIC ACID DERIVATIVES AS DHODH INHIBITORS | 2008 |
|
RU2481334C2 |
DRUG AND METHOD OF TREATMENT OF PATIENTS WITH ELEVATED INTRAOCULAR PRESSURE AND/OR GLAUCOMA | 1995 |
|
RU2123847C1 |
AMINO ALCOHOL DERIVATIVES OR PHOSPHORIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SPECIFIED DERIVATIVES | 2003 |
|
RU2330839C2 |
NOVEL INDOLE DERIVATIVES HAVING IκB KINASE β INHIBITING ACTIVITY | 2008 |
|
RU2470918C2 |
TRICYCLIC CONDENSED HETEROCYCLIC COMPOUNDS, METHOD FOR THEIR PREPARING (VARIANTS) AND PHARMACEUTICAL COMPOSITION | 2000 |
|
RU2211837C2 |
SULPHONAMIDE COMPOUNDS AND USE THEREOF | 2009 |
|
RU2502730C2 |
CHIRAL DIACYL-HYDRAZINE LIGANDS FOR MODULATING EXPRESSION OF EXOGENIC GENES BY MEANS OF ECDYSONE-RECEPTOR COMPLEX | 2008 |
|
RU2490253C2 |
DERIVATIVES OF CYCLIC AMINES, METHOD FOR INHIBITION | 1998 |
|
RU2216540C2 |
DERIVATIVES OF AMINOQUINOLINE AND AMINOPYRIDINE AND THEIR USING AS ADENOSINE LIGANDS A | 2002 |
|
RU2278112C2 |
DERIVATIVES OF 1,3-DIOXOL[4,5-H][2,3]BENZODIAZEPINE AS INHIBITORS OF AMPA/KAINATE RECEPTOR, METHOD FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF TREATMENT | 1998 |
|
RU2208014C2 |
Authors
Dates
2004-12-10—Published
2000-05-25—Filed